From ScienceDaily
Scientists at the Francis Crick Institute and Vividion Therapeutics have discovered chemical compounds that can precisely prevent the cancer-driving gene RAS from connecting with a key pathway responsible for tumor growth.
The potential treatment is now moving into its first human clinical trial. If proven safe and effective, it could become a way to treat a wide range of cancers while minimizing harm to healthy cells.